BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 621526)

  • 21. Aspects and evolution of cerebrovascular accidents.
    Caillé JM; Constant P; Dop A; Latinville D; Laporte A; Henry P
    J Neuroradiol; 1976 Dec; 3(4):297-312. PubMed ID: 1027916
    [No Abstract]   [Full Text] [Related]  

  • 22. Regional cerebral blood flow estimation in the diagnosis of cerebrovascular disease.
    Moses DC; James AE; Strauss HW; Wagner HN
    J Nucl Med; 1972 Feb; 13(2):135-41. PubMed ID: 5008100
    [No Abstract]   [Full Text] [Related]  

  • 23. Experimental thromboembolic stroke studied by positron emission tomography: immediate versus delayed reperfusion by fibrinolysis.
    De Ley G; Weyne J; Demeester G; Stryckmans K; Goethals P; Van de Velde E; Leusen I
    J Cereb Blood Flow Metab; 1988 Aug; 8(4):539-45. PubMed ID: 3260595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute cerebral vascular accident associated with hyperperfusion.
    Soin JS; Burdine JA
    Radiology; 1976 Jan; 118(1):109-12. PubMed ID: 1244639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between regional oxygen utilization and cerebral blood flow in multi-infarct dementia.
    Lenzi GL; Jones T; Moss S
    Acta Neurol Scand Suppl; 1977; 64():248-9. PubMed ID: 268799
    [No Abstract]   [Full Text] [Related]  

  • 26. Local interrelationships of cerebral oxygen consumption and glucose utilization in normal subjects and in ischemic stroke patients: a positron tomography study.
    Baron JC; Rougemont D; Soussaline F; Bustany P; Crouzel C; Bousser MG; Comar D
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):140-9. PubMed ID: 6609928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional cerebral blood flow and oxygen utilization in superficial temporal-middle cerebral artery anastomosis patients: an exploratory definition of clinical problems.
    Grubb RL; Ratcheson RA; Raichle ME; Kliefoth AB; Gado MH
    J Neurosurg; 1979 Jun; 50(6):733-41. PubMed ID: 374689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron tomography in ischemic cerebrovascular disease.
    Frackowiak RS; Wise RJ
    Neurol Clin; 1983 Feb; 1(1):183-200. PubMed ID: 6334225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Positron emission tomography in minor ischemic stroke using oxygen-15 steady-state technique.
    Pozzilli C; Itoh M; Matsuzawa T; Fukuda H; Abe Y; Sato T; Takeda S; Ido T
    J Cereb Blood Flow Metab; 1987 Apr; 7(2):137-42. PubMed ID: 3494026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Positron emission tomography in cerebrovascular disease.
    Powers WJ; Raichle ME
    Clin Neurosurg; 1983; 31():107-16. PubMed ID: 6333951
    [No Abstract]   [Full Text] [Related]  

  • 31. Regional cerebral blood flow measured by xenon-133 and [123I]iodo-amphetamine in patients with cerebrovascular diseases.
    Henriksen L; Vorstrup S; Paulson OB
    Prog Brain Res; 1984; 62():245-52. PubMed ID: 6335918
    [No Abstract]   [Full Text] [Related]  

  • 32. Disturbance of oxidative metabolism of glucose in recent human cerebral infarcts.
    Wise RJ; Rhodes CG; Gibbs JM; Hatazawa J; Palmer T; Frackowiak RS; Jones T
    Ann Neurol; 1983 Dec; 14(6):627-37. PubMed ID: 6606390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nuclear medical diagnosis of cerebrovascular diseases].
    Koch RD; Otto HJ; Morczek A
    Psychiatr Neurol Med Psychol (Leipz); 1970 Feb; 22(2):41-6. PubMed ID: 5508262
    [No Abstract]   [Full Text] [Related]  

  • 34. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?
    Okazawa H; Tsuchida T; Kobayashi M; Arai Y; Pagani M; Isozaki M; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):121-9. PubMed ID: 16896662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diffuse and circumscribed cerebral circulation disorders].
    Deisenhammer E; Hammer B
    Wien Med Wochenschr; 1972 Jul; 122(30):453-5. PubMed ID: 5049622
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivo disturbance of the oxidative metabolism of glucose in human cerebral gliomas.
    Rhodes CG; Wise RJ; Gibbs JM; Frackowiak RS; Hatazawa J; Palmer AJ; Thomas DG; Jones T
    Ann Neurol; 1983 Dec; 14(6):614-26. PubMed ID: 6606389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A controlled study on the effect of pentoxifylline and an ergot alkaloid derivative on regional cerebral blood flow in patients with chronic cerebrovascular disease.
    Hartmann A; Tsuda Y
    Angiology; 1988 May; 39(5):449-57. PubMed ID: 3288016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A comparison of the cerebrovascular responses to CO2 and Diamox in patients with unilateral occlusive cerebral arteries: a H2(15)O PET study].
    Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
    Kaku Igaku; 1995 Jun; 32(6):569-77. PubMed ID: 7674567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abnormal hemispheric blood flow and metabolism in cerebrovascular disease. I. Disordered patterns of hemispheric metabolism.
    Meyer JS; Fukuuchi Y; Shimazu K; Ouchi T; Ericsson AD
    Stroke; 1972; 3(2):141-56. PubMed ID: 4334835
    [No Abstract]   [Full Text] [Related]  

  • 40. [An analysis of regional cerebral blood flows (rCBF) in 120 patients with cerebrovascular disease].
    Shang MQ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Feb; 24(1):30-2, 62. PubMed ID: 1868765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.